From: Design, synthesis and biological potentials of novel tetrahydroimidazo[1,2-a]pyrimidine derivatives
Comp. | Minimum inhibitory concentration (MIC) | ||||
---|---|---|---|---|---|
Bacterial strains | Fungal strains | ||||
S. aureus | B. subtilis | E. coli | C. albicans | A. niger | |
1 | 2.19 | 2.19 | 2.19 | 2.19 | 1.09 |
2 | 4.19 | 2.10 | 2.10 | 1.05 | 1.05 |
3 | 2.27 | 2.27 | 2.27 | 1.13 | 1.13 |
4 | 4.33 | 4.33 | 8.67 | 2.17 | 1.08 |
5 | 9.07 | 1.13 | 9.07 | 2.27 | 1.13 |
6 | 2.27 | 2.27 | 2.27 | 2.27 | 1.13 |
7 | 2.28 | 1.14 | 2.28 | 2.28 | 1.14 |
8 | 2.39 | 2.39 | 2.39 | 2.39 | 1.20 |
9 | 2.26 | 2.26 | 2.26 | 2.26 | 1.13 |
10 | 2.18 | 2.18 | 2.18 | 2.18 | 1.09 |
11 | 2.33 | 1.17 | 2.33 | 2.33 | 1.17 |
12 | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 |
13 | 9.33 | 2.33 | 9.33 | 2.33 | 2.33 |
14 | 2.14 | 2.14 | 2.14 | 2.14 | 2.14 |
15 | 4.16 | 1.04 | 2.08 | 1.04 | 1.04 |
16 | 4.66 | 1.17 | 2.33 | 2.33 | 2.33 |
17 | 2.34 | 1.17 | 2.34 | 2.34 | 1.17 |
18 | 4.63 | 0.58 | 2.31 | 2.31 | 2.31 |
19 | 2.47 | 1.24 | 2.47 | 2.47 | 1.24 |
20 | 2.31 | 1.16 | 2.31 | 1.16 | 2.31 |
21 | 2.21 | 1.10 | 1.10 | 1.10 | 1.10 |
22 | 2.39 | 2.39 | 2.39 | 1.20 | 1.20 |
23 | 4.63 | 1.16 | 2.31 | 2.31 | 2.31 |
24 | 2.35 | 1.17 | 2.35 | 1.17 | 1.17 |
Std. | 0.47a | 0.47a | 0.47a | 0.50b | 0.50b |